Medical Xpress March 23, 2023
By University of Eastern Finland

First-in-human clinical trials have been initiated at Kuopio University Hospital with a device that assists in the identification of cancerous tissue during surgery. The tissue monitoring technique developed by startup company Marginum is based on the interdisciplinary research of the University of Eastern Finland, Kuopio University Hospital Neurosurgery and the Eastern Finland Microsurgery Center.

It is the first time such a tissue recognition technology is brought into the operating theater. “Our goal is to refine the technique into a golden standard for fluorescence-guided surgery,” says Adjunct Professor of Experimental Neurosurgery and Marginum’s Chairman of the Board Antti-Pekka Elomaa.

The aspirate tissue monitor is attached to a surgical suction tube routinely used in the operation, through which the tissue is removed....

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: Clinical Trials, Medical Devices, Provider, Trends
Vertos Medical Raises $26M for Minimally Invasive Spinal Procedure
America’s health care paradox: We need smarter spending, not more
The Current State Of 521 FDA-Approved, AI-Based Medical Devices
Medtech company raises $35M
MedTech Innovator taps 61 startups for accelerator

Share This Article